Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Leach

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
European Urology|May 21, 2018
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsDonna P Ankerst, Johanna Straubinger, Katharina Selig, et al.
BMC Medical Research Methodology|July 21, 2022
Accommodating heterogeneous missing data patterns for prostate cancer risk predictionMatthias Neumair, Michael W Kattan, Stephen J Freedland, et al.
Oncotarget|February 22, 2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancerDebashis Sahoo, Wei Wei, Heidi Auman, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Molecular Cancer Research : MCR|October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic PhenotypeJoseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Cancer Cell|July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerAlfredo Addeo, Pankil K Shah, Natacha Bordry, et al.
Cancer Research Communications|September 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSIJordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, et al.
The Prostate|May 21, 2016
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trialHaitao Chen, Xu Liu, Charles B Brendler, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
European Urology|May 21, 2018
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsDonna P Ankerst, Johanna Straubinger, Katharina Selig, et al.
BMC Medical Research Methodology|July 21, 2022
Accommodating heterogeneous missing data patterns for prostate cancer risk predictionMatthias Neumair, Michael W Kattan, Stephen J Freedland, et al.
Oncotarget|February 22, 2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancerDebashis Sahoo, Wei Wei, Heidi Auman, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Molecular Cancer Research : MCR|October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic PhenotypeJoseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Cancer Cell|July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerAlfredo Addeo, Pankil K Shah, Natacha Bordry, et al.
Cancer Research Communications|September 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSIJordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, et al.
The Prostate|May 21, 2016
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trialHaitao Chen, Xu Liu, Charles B Brendler, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Pageof 13